Product Summary
Traditionally participation in clinical trials required study participants to travel to a physical clinic for a set number of visits outlined in the study protocol. Signant's telemedicine solution offers the option for a subset of those study visits to be virtual, making it more convenient for participants and improving participant retention for the duration of a study.
Site staff and clinicians conduct virtual visits using a browser-based web application. Study participants join visits via a companion mobile application—available for iOS and Android—or the web application.
At the product's core is a purpose-built video encounter room for the clinician to conduct visits with study participants, and up to four guests, virtually.
-
There are two types of virtual visits: scheduled or on-demand.
-
Forms allow clinicians to enter assessment data during the visit.
-
Support for chat, screen sharing, and in-session screenshots.
-
A visit summary for each visit consolidates all data and documentation.
Product Accomplishments
The technology powering Signant's telemedicine solution came with the VirTrial acquisition in late 2020. I led the launch of a new, fully-rebranded platform instance to match Signant SmartSignals marketing standards in the summer of 2022. The launch also included extensive new functionality for our web and mobile applications built in the year following the acquisition. Highlights include:
-
Virtual visit recording and playback
-
Configurable notifications for study needs that aren't handled by system events, e.g., medication reminders.
-
Configurable visit types allow the clinician to complete different forms for different visits, e.g., one form for participant onboarding and another for a follow-up visit for an onsite procedure.
-
Privacy controls during video visits, including background blurring and facial obscuring
-
Forms for study participant data capture separate from a visit.
-
A refined and optimized encounter room user interface
-
Azure hosting in Europe to support EU requirements for the physical location of study data storage.
-
Improved platform compliance with 21 CFR Part 11 requirements
The press release for the launch captures additional details.